1G4R
| |
1G0X
| |
5F8U
| |
8JA3
| Structure of beta-arrestin1 in complex with C3aRpp | 分子名称: | Beta-arrestin-1, C3a anaphylatoxin chemotactic receptor, Fab30 heavy chain, ... | 著者 | Maharana, J, Sarma, P, Yadav, M.K, Chami, M, Banerjee, R, Shukla, A.K. | 登録日 | 2023-05-05 | 公開日 | 2023-12-27 | 最終更新日 | 2024-11-13 | 実験手法 | ELECTRON MICROSCOPY (3.94 Å) | 主引用文献 | Molecular insights into atypical modes of beta-arrestin interaction with seven transmembrane receptors. Science, 383, 2024
|
|
8I0N
| Structure of beta-arrestin1 in complex with a phosphopeptide corresponding to the human C5a anaphylatoxin chemotactic receptor 1, C5aR1 (Local refine) | 分子名称: | Beta-arrestin-1, C5a anaphylatoxin chemotactic receptor 1, Fab30 heavy chain, ... | 著者 | Maharana, J, Sarma, P, Yadav, M.K, Banerjee, R, Shukla, A.K. | 登録日 | 2023-01-11 | 公開日 | 2023-05-17 | 最終更新日 | 2024-10-16 | 実験手法 | ELECTRON MICROSCOPY (3.26 Å) | 主引用文献 | Structural snapshots uncover a key phosphorylation motif in GPCRs driving beta-arrestin activation. Mol.Cell, 83, 2023
|
|
2YCW
| TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST CARAZOLOL | 分子名称: | (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol, BETA-1 ADRENERGIC RECEPTOR, HEGA-10, ... | 著者 | Moukhametzianov, R, Warne, T, Edwards, P.C, Serrano-Vega, M.J, Leslie, A.G.W, Tate, C.G, Schertler, G.F.X. | 登録日 | 2011-03-17 | 公開日 | 2011-06-01 | 最終更新日 | 2023-12-20 | 実験手法 | X-RAY DIFFRACTION (3 Å) | 主引用文献 | Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a Beta-1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
2Y00
| TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND PARTIAL AGONIST DOBUTAMINE (CRYSTAL DOB92) | 分子名称: | BETA-1 ADRENERGIC RECEPTOR, CHOLESTEROL HEMISUCCINATE, DOBUTAMINE, ... | 著者 | Warne, A, Moukhametzianov, R, Baker, J.G, Nehme, R, Edwards, P.C, Leslie, A.G.W, Schertler, G.F.X, Tate, C.G. | 登録日 | 2010-11-30 | 公開日 | 2011-01-12 | 最終更新日 | 2023-12-20 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor Nature, 469, 2011
|
|
2YCX
| TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST CYANOPINDOLOL | 分子名称: | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile, BETA-1 ADRENERGIC RECEPTOR, octyl 1-thio-beta-D-glucopyranoside | 著者 | Moukhametzianov, R, Warne, T, Edwards, P.C, Serrano-Vega, M.J, Leslie, A.G.W, Tate, C.G, Schertler, G.F.X. | 登録日 | 2011-03-17 | 公開日 | 2011-06-01 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (3.25 Å) | 主引用文献 | Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a Beta-1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
2YCY
| TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST CYANOPINDOLOL | 分子名称: | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile, BETA-1 ADRENERGIC RECEPTOR, SODIUM ION, ... | 著者 | Moukhametzianov, R, Warne, T, Edwards, P.C, Serrano-Vega, M.J, Leslie, A.G.W, Tate, C.G, Schertler, G.F.X. | 登録日 | 2011-03-17 | 公開日 | 2011-06-08 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (3.15 Å) | 主引用文献 | Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a {Beta}1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
2YCZ
| TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND ANTAGONIST IODOCYANOPINDOLOL | 分子名称: | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3-iodo-1H-indole-2-carbonitrile, BETA-1 ADRENERGIC RECEPTOR, octyl 1-thio-beta-D-glucopyranoside | 著者 | Moukhametzianov, R, Warne, T, Edwards, P.C, Serrano-Vega, M.J, Leslie, A.G.W, Tate, C.G, Schertler, G.F.X. | 登録日 | 2011-03-17 | 公開日 | 2011-06-01 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (3.65 Å) | 主引用文献 | Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a {Beta}1- Adrenergic Receptor. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
4GPO
| |
4JQI
| Structure of active beta-arrestin1 bound to a G protein-coupled receptor phosphopeptide | 分子名称: | 1,2-ETHANEDIOL, Beta-arrestin-1, CHLORIDE ION, ... | 著者 | Shukla, A.K, Manglik, A, Kruse, A.C, Xiao, K, Reis, R.I, Tseng, W.C, Staus, D.P, Hilger, D, Uysal, S, Huang, L.H, Paduch, M, Shukla, P.T, Koide, A, Koide, S, Weis, W.I, Kossiakoff, A.A, Kobilka, B.K, Lefkowitz, R.J. | 登録日 | 2013-03-20 | 公開日 | 2013-04-17 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | 主引用文献 | Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature, 497, 2013
|
|
7DFB
| Crystal of Arrestin2-V2Rpp-6-7-Fab30 complex | 分子名称: | Beta-arrestin-1, FAB30 HEAVY CHAIN, FAB30 LIGHT CHAIN, ... | 著者 | Sun, J.P, Yu, X, Xiao, P, He, Q.T, Lin, J.Y, Zhu, Z.L. | 登録日 | 2020-11-06 | 公開日 | 2021-07-28 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (3.28 Å) | 主引用文献 | Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2. Nat Commun, 12, 2021
|
|
7DF9
| Crystal of Arrestin2-V2Rpp-1-Fab30 complex | 分子名称: | Beta-arrestin-1, FAB30 HEAVY CHAIN, FAB30 LIGHT CHAIN, ... | 著者 | Sun, J.P, Yu, X, Xiao, P, He, Q.T, Lin, J.Y, Zhu, Z.L. | 登録日 | 2020-11-06 | 公開日 | 2021-07-28 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (3.17 Å) | 主引用文献 | Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2. Nat Commun, 12, 2021
|
|
7DFA
| Crystal of Arrestin2-V2Rpp-4-Fab30 complex | 分子名称: | Beta-arrestin-1, FAB30 HEAVY CHAIN, FAB30 LIGHT CHAIN, ... | 著者 | Sun, J.P, Yu, X, Xiao, P, He, Q.T, Lin, J.Y, Zhu, Z.L. | 登録日 | 2020-11-06 | 公開日 | 2021-07-28 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (2.54 Å) | 主引用文献 | Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2. Nat Commun, 12, 2021
|
|
7DFC
| Crystal of Arrestin2-V2Rpp-3-Fab30 complex | 分子名称: | Beta-arrestin-1, FAB30 HEAVY CHAIN, FAB30 LIGHT CHAIN, ... | 著者 | Sun, J.P, Yu, X, Xiao, P, He, Q.T, Lin, J.Y, Zhu, Z.L. | 登録日 | 2020-11-06 | 公開日 | 2021-07-28 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (2.49 Å) | 主引用文献 | Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2. Nat Commun, 12, 2021
|
|
7EIB
| |
6IDX
| Crystal Structure of BAI1/ELMO2 complex | 分子名称: | Adhesion G protein-coupled receptor B1, Engulfment and cell motility protein 2 | 著者 | Weng, Z.F, Lin, L, Zhu, J.W, Zhang, R.G. | 登録日 | 2018-09-11 | 公開日 | 2019-01-23 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (1.699 Å) | 主引用文献 | Structure of BAI1/ELMO2 complex reveals an action mechanism of adhesion GPCRs via ELMO family scaffolds Nat Commun, 10, 2019
|
|
3ZPR
| Thermostabilised turkey beta1 adrenergic receptor with 4-methyl-2-(piperazin-1-yl) quinoline bound | 分子名称: | 4-METHYL-2-(PIPERAZIN-1-YL) QUINOLINE, BETA-1 ADRENERGIC RECEPTOR, CHOLESTEROL HEMISUCCINATE, ... | 著者 | Christopher, J.A, Congreve, M, Dore, A.S, Marshall, F.H, Myszka, D.G, Brown, J, Koglin, M, Tehan, B, Errey, J.C, Tate, C.G, Warne, T. | 登録日 | 2013-03-01 | 公開日 | 2013-04-03 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Biophysical Fragment Screening of the Beta1-Adrenergic Receptor: Identification of High Affinity Aryl Piperazine Leads Using Structure-Based Drug Design. J.Med.Chem., 56, 2013
|
|
9BT8
| Structure of Src in complex with beta-arrestin 1 revealing SH3 binding sites | 分子名称: | Antibody fragment Fab30, heavy chain, light chain, ... | 著者 | Pakharukova, N, Bansia, H, Bassford, D.K, des Georges, A, Lefkowitz, R.J. | 登録日 | 2024-05-14 | 公開日 | 2024-11-13 | 実験手法 | ELECTRON MICROSCOPY (3.34 Å) | 主引用文献 | Beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopy. Biorxiv, 2024
|
|
9CX9
| Structure of SH3 domain of Src in complex with beta-arrestin 1 | 分子名称: | Antibody fragment Fab30, heavy chain, light chain, ... | 著者 | Pakharukova, N, Bansia, H, Lefkowitz, R.J, des Georges, A. | 登録日 | 2024-07-31 | 公開日 | 2024-11-13 | 実験手法 | ELECTRON MICROSCOPY (3.34 Å) | 主引用文献 | Beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopy. Biorxiv, 2024
|
|
4AMJ
| Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist carvedilol | 分子名称: | (2S)-1-(8H-CARBAZOL-4-YLOXY)-3-[2-(2-METHOXYPHENOXY)ETHYLAMINO]PROPAN-2-OL, BETA-1 ADRENERGIC RECEPTOR, HEGA-10, ... | 著者 | Warne, T, Edwards, P.C, Leslie, A.G, Tate, C.G. | 登録日 | 2012-03-12 | 公開日 | 2012-05-23 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | Crystal Structures of a Stabilized Beta1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol Structure, 20, 2012
|
|
4AMI
| Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist bucindolol | 分子名称: | 2-[(2S)-3-[[1-(1H-indol-3-yl)-2-methyl-propan-2-yl]amino]-2-oxidanyl-propoxy]benzenecarbonitrile, BETA-1 ADRENERGIC RECEPTOR, HEGA-10 | 著者 | Warne, T, Edwards, P.C, Leslie, A.G, Tate, C.G. | 登録日 | 2012-03-11 | 公開日 | 2012-05-23 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (3.2 Å) | 主引用文献 | Crystal Structures of a Stabilized Beta1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol Structure, 20, 2012
|
|
3ZPQ
| Thermostabilised turkey beta1 adrenergic receptor with 4-(piperazin-1- yl)-1H-indole bound (compound 19) | 分子名称: | 4-(PIPERAZIN-1-YL)-1H-INDOLE, BETA-1 ADRENERGIC RECEPTOR, CHOLESTEROL HEMISUCCINATE, ... | 著者 | Christopher, J.A, Congreve, M, Dore, A.S, Marshall, F.H, Myszka, D.G, Brown, J, Koglin, M, Tehan, B, Errey, J.C, Tate, C.G, Warne, T. | 登録日 | 2013-03-01 | 公開日 | 2013-04-03 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (2.8 Å) | 主引用文献 | Biophysical Fragment Screening of the Beta1-Adrenergic Receptor: Identification of High Affinity Aryl Piperazine Leads Using Structure-Based Drug Design. J.Med.Chem., 56, 2013
|
|
9CX3
| Structure of SH3 domain of Src in complex with beta-arrestin 1 | 分子名称: | Antibody fragment Fab30, heavy chain, light chain, ... | 著者 | Pakharukova, N, Bansia, H, des Georges, A, Lefkowitz, R.J. | 登録日 | 2024-07-30 | 公開日 | 2024-11-13 | 実験手法 | ELECTRON MICROSCOPY (3.47 Å) | 主引用文献 | Beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopy. Biorxiv, 2024
|
|